Largest biotech companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech companies ranked by earnings, at PLN 34.3B, ahead of Amgen (PLN 31B) and Biogen (PLN 5.2B). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesPLN 34.3B
- Median
- -PLN 276M
- Combined market value
- PLN 3.38T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | PLN 34.3B | PLN 845.4B | PLN 681.61 | 0.54% down | 33% up | ||
| 2 | AmgenAMGN · Health Care | PLN 31B | PLN 973B | PLN 1,798.77 | 2.41% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | PLN 5.2B | PLN 148.7B | PLN 1,006.02 | 0.34% down | 49% up | ||
| 4 | argenxARGX · Health Care | PLN 5.2B | PLN 238.4B | PLN 3,790.90 | 0.60% down | 4% up | ||
| 5 | ExelixisEXEL · Health Care | PLN 3.1B | PLN 67.8B | PLN 278.04 | 0.84% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | PLN 1.9B | PLN 66.3B | PLN 654.62 | 1.98% down | 20% up | ||
| 7 | QiagenQGEN · Health Care | PLN 1.7B | PLN 41.2B | PLN 199.40 | 0.42% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | PLN 1.3B | PLN 44.5B | PLN 390.22 | 1.02% up | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | PLN 824.4M | PLN 37.1B | PLN 1,250.84 | 4.09% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | PLN 732M | PLN 46B | PLN 292.71 | 0.13% up | 26% up | ||
| 11 | RepligenRGEN · Health Care | PLN 196.8M | PLN 43.7B | PLN 683.80 | 4.75% up | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -PLN 239.5M | PLN 18.3B | PLN 113.06 | 1.40% down | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -PLN 312.6M | PLN 31.6B | PLN 463.11 | 2.73% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -PLN 648M | PLN 29.1B | PLN 325.34 | 2.39% up | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -PLN 925.6M | PLN 25.4B | PLN 388.02 | 0.41% down | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -PLN 1.3B | PLN 41.4B | PLN 484.93 | 0.86% down | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -PLN 1.4B | PLN 28.2B | PLN 26.50 | 5.19% up | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -PLN 1.5B | PLN 23B | PLN 188.73 | 4.02% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -PLN 2B | PLN 27.9B | PLN 134.88 | 0.90% up | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -PLN 2.3B | PLN 16.2B | PLN 167.33 | 3.55% up | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -PLN 3.1B | PLN 37.5B | PLN 237.03 | 0.86% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -PLN 4.6B | PLN 139B | PLN 642.70 | 1.85% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -PLN 5.1B | PLN 84B | PLN 338.66 | 0.85% down | 16% down | ||
| 24 | ModernaMRNA · Health Care | -PLN 11.4B | PLN 329.3B | PLN 813.87 | 2.22% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0249 PLN).
Questions and answers
Which biotech companies rank first by earnings?
Gilead Sciences (PLN 34.3B), Amgen (PLN 31B) and Biogen (PLN 5.2B) are the top three of the 24 biotech companies ranked by earnings as of 18 Nov 2026, 16:47 UTC.
How many biotech companies are in this ranking?
24 are ranked by earnings.
What are these biotech companies worth together?
The 24 biotech companies ranked by earnings have a combined market value of PLN 3.38T as of 18 Nov 2026, 16:47 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.